Literature DB >> 6181092

Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells.

J A Killen, R H Swanborg.   

Abstract

Suppressor cells that regulate experimental allergic encephalomyelitis (EAE) are present in lymph nodes of Lewis rats that have recovered from the disease, as demonstrated by adoptive transfer of suppression for at least 108 days following challenge of donor rats with myelin basic protein (BP) in complete Freund's adjuvant (CFA). These suppressor lymph node cells (LNC) inhibit the occurrence of active, but not passive EAE in recipients, suggesting that they function early in the inductive phase of the response to BP. The suppressor cells are nylon-adherent, and suppression can be partially abrogated by depletion of B cells with anti-immunoglobulin (ig) and complement (C). Serum from recovered donors has, at best, only a modest suppressive effect when transfused into syngeneic recipients. These findings suggest that the B cells do not mediate suppression on EAE via production of blocking antibody, but may function directly, perhaps by triggering T cells to become suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6181092     DOI: 10.1016/0165-5728(82)90049-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

1.  Suppression of actively induced experimental autoimmune uveoretinitis by CD4+ T cells.

Authors:  E Uchio; M Kijima; M Ishioka; S Tanaka; S Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

2.  Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat.

Authors:  T Smith; A K Hewson; C I Kingsley; J P Leonard; M L Cuzner
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide.

Authors:  I A MacPhee; M J Day; D W Mason
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

4.  Inducible immune regulation following autoimmune disease in the immune-privileged eye.

Authors:  Nobuyoshi Kitaichi; Kenichi Namba; Andrew W Taylor
Journal:  J Leukoc Biol       Date:  2005-01-12       Impact factor: 4.962

5.  Murine V lambda x and V lambda x-containing antibodies bind human myelin basic protein.

Authors:  F S Galin; C C Maier; S R Zhou; J N Whitaker; J E Blalock
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

Review 6.  Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation.

Authors:  Andrew Jones; Daniel Hawiger
Journal:  Front Immunol       Date:  2017-05-09       Impact factor: 7.561

Review 7.  Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases.

Authors:  Courtney A Iberg; Daniel Hawiger
Journal:  Antibodies (Basel)       Date:  2020-06-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.